Endovia Health Sciences, Inc.
EDVA
13 hedge funds and large institutions have $919K invested in Endovia Health Sciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
44% more funds holding
Funds holding: 9 → 13 (+4)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
9% less capital invested
Capital invested by funds: $1.01M → $919K (-$94K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$335K |
| 2 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
+$282K |
| 3 |
OC
Oppenheimer & Co
New York
|
+$66K |
| 4 |
Jane Street
New York
|
+$62.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$44.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
-$182K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$129K |
| 3 |
VF
Virtu Financial
New York
|
-$84K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.68K |
| 5 |
BWA
BDO Wealth Advisors
Jacksonville,
Florida
|
-$6K |
EDVA Hedge Fund Activity: Q3 2021 in Review
13 of the 5,727 institutional investors tracked by Wall St. Rank reported a position in Endovia Health Sciences, Inc. (EDVA) for Q3 2021, worth a combined $919K — down 9.3% from $1.01M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new EDVA positions and 3 closed out — a net gain of 4 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $335K. The largest seller was Shay Capital, exiting entirely with an estimated $182K sold.
- 13 institutional investors held Endovia Health Sciences, Inc. (EDVA) as of Q3 2021, up from 9 in Q2 2021.
- Funds reported $919K of Endovia Health Sciences, Inc. stock for Q3 2021, down 9.3% quarter-over-quarter.
- 7 funds opened new Endovia Health Sciences, Inc. positions in Q3 2021 and 3 closed out, a net change of +4 holders.
- The largest Endovia Health Sciences, Inc. buyer in Q3 2021 was Millennium Management, an estimated $335K added.
- The largest Endovia Health Sciences, Inc. seller in Q3 2021 was Shay Capital, an estimated $182K sold.
Based on aggregated 13F filings for Q3 2021.